5885 Hollis Street
59 articles with Amyris, Inc.
2/15/2019Pharma and biotech companies strengthen their leadership teams with new hires and appointments at Cadent, bluebird, Abeona, Sanofi, and more.
Amyris, Inc. today announced that it has executed an expanded agreement for its existing production contract with ADL Bionatur Solutions (MAB:ADL), through its fermentation division ADL Biopharma.
Amyris Enters into Extensive Collaboration Agreement with Leading Chinese Pharmaceutical Company, Yifan Pharmaceutical Co., Ltd.
Amyris, Inc. today announced that it has entered into a multi-year, multi-million-dollar agreement with a subsidiary of Yifan Pharmaceutical Co., Ltd.
The San Francisco Business Times and the Silicon Valley Business Journal pulled together to create a list of the Best Places to Work in the Bay Area. Hitting the list at number 23 for large companies is biotechnology company Amyris.
Amyris, Inc. Enters Into First Product Development And Production Agreement With Royal DSM For Food And Nutrition Molecule
Amyris, Inc. Announces Multi-Year Technology Investment Agreement With Defense Advanced Research Projects Agency Worth Up To $35 Million
Amyris, Inc. To Enter Into Exclusive Cosmetic Distribution Partnership With Leading Brazil Cosmetic Retailer
Amyris, Inc. And Infectious Disease Research Institute (IDRI) Announce Agreement To Explore Testing And Development Of Amyris Materials For Use In Vaccine Adjuvant Formulations
Amyris, Inc. To Present At Rodman & Renshaw 17th Annual Global Investment Conference On September 9, 2015
Amyris, Inc. Set To Increase Global Growth Of Its Cosmetic Emollients Through ISO 22716 Certification
Amyris, Inc. Achieves Breakthrough Performance With 2nd Fragrance Molecule Ready For Industrial Scale Fermentation In Less Than 12 Months
Amyris, Inc. & Genome Compiler Launch Testing Program For Pharma And Biotech Companies To Explore DNA Design And Construction Solutions
Amyris, Inc. Signing Of Agreements For Conversion And Restructuring Of Approximately $175 Million Of Convertible Debt And $25 Million Private Placement
Amyris, Inc. And Ipca Laboratories Sign Letter Of Intent For Development And Supply Of Active Pharmaceutical Ingredients
Amyris, Inc. Announces Designation Of Bram Klaeijsen, Seasoned Global Business Leader From Cargill Incorporated To Board Of Directors